ROCK2 and Alzheimer disease: As Rock2 accumulates in the earliest stages of AD and remains elevated throughout the disease progression (Herskowitz et al., 2013), our data set the basis for a future development of therapeutic strategies to overcome neuronal loss and memory impairment in AD.